These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 20198302)
1. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma. Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302 [TBL] [Abstract][Full Text] [Related]
2. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models. Futami K; Kumagai E; Makino H; Sato A; Takagi M; Shimamoto A; Furuichi Y Cancer Sci; 2008 Jun; 99(6):1227-36. PubMed ID: 18422747 [TBL] [Abstract][Full Text] [Related]
3. RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer. Sanada S; Futami K; Terada A; Yonemoto K; Ogasawara S; Akiba J; Yasumoto M; Sumi A; Ushijima K; Kamura T; Furuichi Y; Yano H PLoS One; 2013; 8(8):e72820. PubMed ID: 23951333 [TBL] [Abstract][Full Text] [Related]
4. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Futami K; Kumagai E; Makino H; Goto H; Takagi M; Shimamoto A; Furuichi Y Cancer Sci; 2008 Jan; 99(1):71-80. PubMed ID: 17953710 [TBL] [Abstract][Full Text] [Related]
5. RECQL1 plays an important role in the development of tongue squamous cell carcinoma. Tao J; Tao S; Han J; Zhou Z; Zhang X; Wang H; Chen R; Ji F; Zhu Y Cell Physiol Biochem; 2014; 33(5):1579-90. PubMed ID: 24854846 [TBL] [Abstract][Full Text] [Related]
6. RECQL1 and WRN DNA repair helicases: potential therapeutic targets and proliferative markers against cancers. Futami K; Furuichi Y Front Genet; 2014; 5():441. PubMed ID: 25620975 [TBL] [Abstract][Full Text] [Related]
7. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo. Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196 [TBL] [Abstract][Full Text] [Related]
8. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560 [TBL] [Abstract][Full Text] [Related]
9. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma. Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982 [TBL] [Abstract][Full Text] [Related]
10. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma. Arai A; Chano T; Futami K; Furuichi Y; Ikebuchi K; Inui T; Tameno H; Ochi Y; Shimada T; Hisa Y; Okabe H Cancer Res; 2011 Jul; 71(13):4598-607. PubMed ID: 21571861 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
12. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer. Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877 [TBL] [Abstract][Full Text] [Related]
13. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma. Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301 [TBL] [Abstract][Full Text] [Related]
14. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers. Arora A; Parvathaneni S; Aleskandarany MA; Agarwal D; Ali R; Abdel-Fatah T; Green AR; Ball GR; Rakha EA; Ellis IO; Sharma S; Madhusudan S Mol Cancer Ther; 2017 Jan; 16(1):239-250. PubMed ID: 27837030 [TBL] [Abstract][Full Text] [Related]
16. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
18. Lentiviral-mediated short hairpin RNA silencing of APE1 suppresses hepatocellular carcinoma proliferation and migration: A potential therapeutic target for hepatoma treatment. Zheng ZH; Du W; Li YJ; Gao MQ; Huang AM; Liu JF Oncol Rep; 2015 Jul; 34(1):95-102. PubMed ID: 25976295 [TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma. Makita Y; Murata S; Katou Y; Kikuchi K; Uejima H; Teratani M; Hoashi Y; Kenjo E; Matsumoto S; Nogami M; Otake K; Kawamata Y Biochem Biophys Res Commun; 2017 Nov; 493(1):800-806. PubMed ID: 28843857 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma. Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]